Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy vs BSC in metastatic esophageal squamous cell carcinoma (E-DIS)
NCT01248299Phase 2Terminated
- Sponsor
- Centre Oscar Lambret
- Start
- Jan 2011
- Primary completion
- Jan 2016
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, Cisplatin micelle injection (HA132), oxaliplatin, docetaxel in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Centre Oscar Lambret. Started Jan 2011; status: terminated.
02
Drugs
fluorouracilCisplatin micelle injection (HA132)oxaliplatindocetaxel
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01248299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248299.